- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06418828
Patients With Type B Aortic Dissection Returning to Work After Discharge:a Cross-sectional Survey
Cross-sectional Survey and Prediction Model Construction of Patients With Type B Aortic Dissection Returning to Work After Discharge
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Yanjuan Lin, MD
- Phone Number: +86 591 8621 8336
- Email: fjxhyjl@163.com
Study Locations
-
-
Fujian
-
Fuzhou, Fujian, China, 350000
- Recruiting
- Fujian Medical University Union Hospital
-
Contact:
- Yanjuan Lin, MD
- Phone Number: +86 591 8621 8336
- Email: fjxhyjl@163.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
( 1 ) TBAD was diagnosed by computed tomography angiography ( CTA ) or magnetic resonance angiography ( MRA ) ; ( 2 ) 18 years ≤ age < 60 years at diagnosis ; ( 3 ) having full-time or part-time job at the time of diagnosis ; ( 4 ) TBAD patients were discharged after successful treatment and the discharge time was ≥ 6 months ;
Exclusion Criteria:
( 1 ) reaching the retirement age 6 months after discharge ; ( 2 ) those with disturbance of consciousness, mental illness, inability to complete the interview independently or under the guidance of the researcher ; ( 3 ) Participate in other related research ; ( 4 ) Clinical end-stage or receiving palliative treatment.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Return to work group
Asked whether the patient returned to work, if the patient returned to work, included in this group.
|
Ask patients if they are going back to work
|
|
Non-return to work group
Ask whether the patient returned to work, if the patient did not return to work, included in this group.
|
Ask patients if they are going back to work
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of return to work
Time Frame: Six months after discharge,
|
the incidence of returning to work was calculated according to whether the included patients could return to work.
|
Six months after discharge,
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024KY049
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.